SI1866650T1 - Nevrodegenerativni markerji za depresijo - Google Patents

Nevrodegenerativni markerji za depresijo

Info

Publication number
SI1866650T1
SI1866650T1 SI200630658T SI200630658T SI1866650T1 SI 1866650 T1 SI1866650 T1 SI 1866650T1 SI 200630658 T SI200630658 T SI 200630658T SI 200630658 T SI200630658 T SI 200630658T SI 1866650 T1 SI1866650 T1 SI 1866650T1
Authority
SI
Slovenia
Prior art keywords
depression
markers
disease
values
alzheimer
Prior art date
Application number
SI200630658T
Other languages
English (en)
Inventor
Aye Mu Myint
Manfred Schawaller
Robert Verkerk
Markus J Schwarz
Norbert Muller
Original Assignee
Verstappen Leopold
Univ Maastricht
Univ Antwerp
Klinik Und Poliklinik Fur Psychiatrie Und Psychotherapie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Verstappen Leopold, Univ Maastricht, Univ Antwerp, Klinik Und Poliklinik Fur Psychiatrie Und Psychotherapie filed Critical Verstappen Leopold
Publication of SI1866650T1 publication Critical patent/SI1866650T1/sl

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/145555—Hetero-N

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Eye Examination Apparatus (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Mushroom Cultivation (AREA)
  • Input From Keyboards Or The Like (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
SI200630658T 2005-04-06 2006-03-30 Nevrodegenerativni markerji za depresijo SI1866650T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05007558 2005-04-06
PCT/EP2006/002907 WO2006105907A1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for psychiatric conditions
EP06723873A EP1866650B1 (en) 2005-04-06 2006-03-30 Neurodegenerative markers for depression.

Publications (1)

Publication Number Publication Date
SI1866650T1 true SI1866650T1 (sl) 2010-12-31

Family

ID=36293430

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630658T SI1866650T1 (sl) 2005-04-06 2006-03-30 Nevrodegenerativni markerji za depresijo

Country Status (14)

Country Link
US (2) US20080131921A1 (sl)
EP (2) EP2146209B1 (sl)
JP (1) JP4958893B2 (sl)
AT (2) ATE534038T1 (sl)
CY (1) CY1110116T1 (sl)
DE (1) DE602006014379D1 (sl)
DK (2) DK1866650T3 (sl)
ES (2) ES2377704T3 (sl)
HK (1) HK1137219A1 (sl)
NO (2) NO20075671L (sl)
PL (2) PL2146209T3 (sl)
PT (2) PT2146209E (sl)
SI (1) SI1866650T1 (sl)
WO (1) WO2006105907A1 (sl)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008016101A1 (fr) * 2006-08-04 2008-02-07 Ajinomoto Co., Inc. Procédé d'évaluation de stress, appareil d'évaluation de stress, système d'évaluation de stress, programme d'évaluation de stress et support d'enregistrement associé
AT9843U1 (de) * 2007-03-27 2008-04-15 Kepplinger Berthold Dr Messung von biologischen markern
BRPI0906858B8 (pt) 2008-01-18 2021-07-27 Harvard College métodos in vitro para detectar a presença de uma célula de câncer em um indivíduo e para identificar uma assinatura específica de tumor em um indivíduo tendo câncer.
WO2009096502A1 (ja) * 2008-01-31 2009-08-06 Japan As Represented By President Of National Center Of Neurology And Psychiatry うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断
WO2009100243A2 (en) * 2008-02-05 2009-08-13 University Of Miami Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients
CN104777314B (zh) 2009-08-12 2017-01-04 福满代谢组技术有限公司 抑郁症的生物标记物、抑郁症的生物标记物的测定方法、计算机程序及记录介质
EP2596116A4 (en) 2010-07-23 2014-03-19 Harvard College METHODS FOR DETECTION OF AUTOIMMUNE OR IMMUNE-RELATED DISEASES / PATHOLOGIES
AU2011280936A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting prenatal or pregnancy-related diseases or conditions
US20120053073A1 (en) 2010-07-23 2012-03-01 President And Fellows Of Harvard College Methods for Detecting Signatures of Disease or Conditions in Bodily Fluids
BR112013001752A2 (pt) 2010-07-23 2016-05-31 Harvard College método de detectar doenças ou condições usando células fagocídicas
EP2778233B1 (en) 2011-11-10 2017-01-11 Human Metabolome Technologies, Inc. Method for measuring ethanolamine phosphate
CN104603289A (zh) 2012-06-15 2015-05-06 哈里·斯泰利 检测疾病或病状的方法
BR112014031414A2 (pt) 2012-06-15 2017-06-27 Stylli Harry métodos de detectar doenças ou condições utilizando células doentes circulantes
US20150285805A1 (en) 2012-11-05 2015-10-08 Ospedale San Raffaele S.R.L. Biomarkers of multiple myeloma development and progression
EP2965086A4 (en) 2013-03-09 2017-02-08 Harry Stylli Methods of detecting prostate cancer
US10494675B2 (en) 2013-03-09 2019-12-03 Cell Mdx, Llc Methods of detecting cancer
EP2799878A1 (en) * 2013-05-03 2014-11-05 SALION GmbH In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker.
US20160003857A1 (en) * 2014-07-02 2016-01-07 Cecil Bennett Methods and systems for detecting polypharmacy
WO2016040843A1 (en) 2014-09-11 2016-03-17 Harry Stylli Methods of detecting prostate cancer
WO2017185085A1 (en) * 2016-04-22 2017-10-26 Board Of Regents Of The University Of Nebraska Biomarkers for monitoring immune transformation
EP3413050A1 (en) * 2017-06-08 2018-12-12 SALION GmbH In vitro method for the determination of neurodegenerative diseases
CA3077211A1 (en) * 2017-09-27 2019-04-04 University of North Carolina Wilmington Human waste water and human-derived pathogen scouting tool
KR102699211B1 (ko) 2018-03-19 2024-08-26 후지필름 가부시키가이샤 정신 질환의 판정 방법
EP3769797A4 (en) * 2018-03-22 2021-12-15 JAPAN Medical Device Technology Co., Ltd. BIOABSORBABLE ENDOPROTHESIS
KR102159344B1 (ko) * 2019-08-05 2020-09-23 한국과학기술연구원 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법
US20220412908A1 (en) * 2019-11-26 2022-12-29 Kyocera Corporation Stress measurement system and stress measurement method
WO2022075354A1 (en) * 2020-10-06 2022-04-14 Okinawa Institute Of Science And Technology School Corporation A method for obtaining an index for the diagnosis of alzheimer's disease (ad)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6194217B1 (en) * 1980-01-14 2001-02-27 Esa, Inc. Method of diagnosing or categorizing disorders from biochemical profiles
JP2000131318A (ja) * 1998-10-22 2000-05-12 Nikken Foods Co Ltd 快・不快ストレス状態解析方法
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
FR2827045B1 (fr) * 2001-07-05 2007-08-10 Univ Pasteur Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments
JP2004198325A (ja) * 2002-12-19 2004-07-15 Oriental Yeast Co Ltd ストレスの測定方法

Also Published As

Publication number Publication date
CY1110116T1 (el) 2015-01-14
PT2146209E (pt) 2011-12-30
PL2146209T3 (pl) 2012-05-31
ES2346467T3 (es) 2010-10-15
EP1866650A1 (en) 2007-12-19
EP2146209A1 (en) 2010-01-20
NO20075671L (no) 2007-11-06
ES2377704T3 (es) 2012-03-30
PT1866650E (pt) 2010-06-01
DK1866650T3 (da) 2010-09-06
JP4958893B2 (ja) 2012-06-20
DK2146209T3 (da) 2012-02-13
PL1866650T3 (pl) 2011-04-29
HK1137219A1 (en) 2010-07-23
NO20120452L (no) 2007-11-06
ATE468537T1 (de) 2010-06-15
ATE534038T1 (de) 2011-12-15
US20120196300A1 (en) 2012-08-02
EP2146209B1 (en) 2011-11-16
WO2006105907A1 (en) 2006-10-12
JP2008537111A (ja) 2008-09-11
US20080131921A1 (en) 2008-06-05
DE602006014379D1 (de) 2010-07-01
EP1866650B1 (en) 2010-05-19

Similar Documents

Publication Publication Date Title
PL1866650T3 (pl) Neurodegeneracyjne markery depresji
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX2007016136A (es) Metodo para diagnosticar la enfermedad de alzheimer.
WO2005047484A3 (en) Biomarkers for alzheimer's disease
HK1128684A1 (en) Isotopically-labeled benzofuran compounds as imagingagents foramyloidogenic proteins
WO2007023444A3 (en) A method for evaluation of a gemstone
EP1700096A4 (en) PROOF OF PROTEINS AND PRIONS WITH CHANGED CONFORMATION
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
WO2007106762A3 (en) Alzheimer's disease biomarkers and methods of use
EP1948831A4 (en) ALZHEIMER ASSOCIATED GENETIC POLYMORPHISMS, DETECTION METHOD AND USE THEREOF
ZA200810528B (en) Procedure and methods for detecting Alzheimer's disease
IL218190A0 (en) Reaction chamber assemblies for measuring the lipopolysaccharide in exhaled breath condensate
FR2874675B1 (fr) Frein pour roue avec capteur d'usure
ZA200603178B (en) Quick test for the diagnosis of Alzheimer's disease
AU2374302A (en) Means for detecting pathological transformation of the app protein and their uses
EP2073158A3 (en) Recycling system
WO2010043393A8 (en) Use of biglycan in the assessment of heart failure
WO2007066129A3 (en) A method of detecting skeletal muscle damage
WO2007066131A3 (en) A method of detecting skeletal muscle damage
ATE414904T1 (de) Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo
DK1639139T3 (da) Fremgangsmåder til påvisning af Alzheimers sygdom
GB0622194D0 (en) Method for diagnosing or detecting alzheimer's disease
HK1110388A1 (en) Fragment of neurosecretory protein vgf as a biomarker for alzheimer's disease
GB2431273B (en) Narrow inclined vehicle sensing region
GB0506410D0 (en) Apparatus for indicating a person's driving ability